EUVIMEDEUVIMED entdecken
Crossref

Mutating a flexible region of the RSV F protein can stabilize the prefusion conformation

Yu Liang iD, Shuai Shao iD, Xin Yu Li, Zi Xin Zhao, Ning Liu, Zhao Ming Liu, Fu Jie Shen, Hao Zhang, Jun Wei Hou, Xue Feng Zhang, Yu Qin Jin, Li Fang Du und 4 weitere

Science · 2024

DOI: 10.1126/science.adp2362 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, 2024. Verfasst von Yu Liang und 15 weiteren Autor:innen. Beteiligte Einrichtung: The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing 101111, China. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus Vaccines, Respiratory Syncytial Virus, Human, Viral Fusion Proteins. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The respiratory syncytial virus (RSV) fusion (F) glycoprotein is highly immunogenic in its prefusion (pre-F) conformation. However, the protein is unstable, and its conformation must be stabilized for it to function effectively as an immunogen in vaccines. We present a mutagenesis strategy to arrest the RSV F protein in its pre-F state by blocking localized changes in protein structure that accompany large-scale conformational rearrangements. We generated a series of mutants and screened them in vitro to assess their potential for forming a stable pre-F. In animals, the immunogenicity of a representative mutant F protein, with a conformation confirmed by cryo–electron microscopy, elicited levels of neutralizing antibodies and protection against RSV-induced lung damage that were comparable to those of DS-Cav1, a pre-F used in a licensed vaccine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsRespiratory Syncytial Virus VaccinesRespiratory Syncytial Virus, HumanViral Fusion ProteinsAnimalsHumansMiceAntibodies, NeutralizingAntibodies, ViralCryoelectron MicroscopyImmunogenicity, VaccineLungMice, Inbred BALB CMutagenesisMutationProtein ConformationProtein Stability

Substanzen

Antibodies, NeutralizingAntibodies, ViralF protein, human respiratory syncytial virusRespiratory Syncytial Virus VaccinesViral Fusion Proteins

Autor:innen und Institutionen

  • The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing 101111, China.
  • National Engineering Center for New Vaccine Research, Beijing 101111, China.

ORCID-Profile: Yu Liang, Shuai Shao, Jing Zhang, Ji Guo Su, Qi Ming Li

Zitieren

APA

Liang, Y., Shao, S., Li, X. Y., Zhao, Z. X., Liu, N., Liu, Z. M., Shen, F. J., Zhang, H., Hou, J. W., Zhang, X. F., Jin, Y. Q., Du, L. F., Li, X., Zhang, J., Su, J. G., & Li, Q. M. (2024). Mutating a flexible region of the RSV F protein can stabilize the prefusion conformation. Science. https://doi.org/10.1126/science.adp2362

Vancouver

Liang Y, Shao S, Li XY, Zhao ZX, Liu N, Liu ZM, et al. Mutating a flexible region of the RSV F protein can stabilize the prefusion conformation. Science. 2024. doi:10.1126/science.adp2362

BibTeX
@article{Liang2024,
  author = {Liang, Yu and Shao, Shuai and Li, Xin Yu and Zhao, Zi Xin and Liu, Ning and Liu, Zhao Ming and Shen, Fu Jie and Zhang, Hao and Hou, Jun Wei and Zhang, Xue Feng and Jin, Yu Qin and Du, Li Fang and Li, Xin and Zhang, Jing and Su, Ji Guo and Li, Qi Ming},
  title = {Mutating a flexible region of the RSV F protein can stabilize the prefusion conformation},
  journal = {Science},
  year = {2024},
  doi = {10.1126/science.adp2362}
}
Kostenlos starten →